Brief: Praxis Precision Q1 EPS USD -3.29 Vs. IBES Estimate USD -3.2
May 02 (Reuters) - Praxis Precision Q1 operating expenses USD 74.728 million. Q1 operating income USD -74.728 million vs. IBES estimate USD -67.8 million Q1 net income USD -69.296 million vs. IBES estimate USD -64.3 million
Recent news on Praxis Precision Medicines
See all newsUS RESEARCH ROUNDUP-Arxis, Cigna, Vylor
Brief: Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Praxis Precision Medicines, Inc. reports results for the quarter ended June 30 - Earnings Summary
Praxis Precision Q2 net loss widens on higher expenses
Brief: Praxis Precision Q2 EPS USD -2.87